evidence table
Zinc Acne Randomized Trial Evidence Table
Structured evidence table for Zinc Acne Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Zinc Acne Randomized Trial | These treatments show varying degrees of efficacy and improved safety profiles, but most lack head-to-head comparisons with isotretinoin. | 4 | Tommasino N (2026) | Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate-to-Severe Acne. |
| Zinc Acne Randomized Trial | Conclusion Several systemic options beyond isotretinoin have emerged, showing potential in specific subgroups or as adjunctive therapies. | 4 | Tommasino N (2026) | Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate-to-Severe Acne. |
| Zinc Acne Randomized Trial | However, further large-scale comparative studies are needed to define their roles within evidence-based acne management algorithms. | 4 | Tommasino N (2026) | Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate-to-Severe Acne. |
| Zinc Acne Randomized Trial | Background Acne vulgaris is a common inflammatory skin disorder with significant psychosocial impact. | 4 | Tommasino N (2026) | Beyond Isotretinoin: A Narrative Review of Emerging Systemic Therapies for Moderate-to-Severe Acne. |
Source documents